E-mail answer from my banker to a couple of questions.~~~~~

New Post Public Reply Private Reply Replies (0) Message Board
copytele
209
E-mail answer from my banker to a couple of questions.~~~~~ That’s quite a broad subject to comment on, but I’m glad to try:



Trump is far from perfect, most of us knew that going in. He’s been soft on the enormous budget deficit which seems to be stuck north of 1T annually; his tweets are too often acerbic and offensive to the undecided voters, not to mention sometimes just stupid (e.g., never heard of a Cat 5 hurricane and thought Dorian might hit Alabama); he flips and flops and contradicts himself, which would be OK only if it’s a sly negotiating tactic but I suspect often it isn’t; he too often drives away good people from his administration, like Gen Mattis; etc.


All that having been said, he has been fighting tremendous headwinds ever since he was elected: The Deep State, the “Russia collusion” lie/fiasco, bitter hatred from the mainstream media, from academia, from Hollywood, and from all those other American institutions which have been swayed/cajoled/bludgeoned by the Left. I don’t believe any other president in history has had to endure a fraction of the vicious attacks he has been subjected to. And not just him, but his wife, his family, his associates, and his MAGA hat wearing supporters.


Despite all the terrible opposition, he has accomplished a lot: Two excellent Supreme Court justices (hurry up and die, RBG, so he can make it three. Yeah, that’s terribly unchristian of me, but I can’t help it!), a rollback of numerous Deep State regulations despite the headwinds described above, a re-setting of international relationships with our allies so that we’re not played for the money-dispensing suckers which we had become, noble attempts to stem illegal immigration, and to change immigration policy so that legal immigrants are selected who can best benefit America. Also, he has “bitten the bullet”, or “taken the bull by the horns” (take your pick of metaphors) by confronting North Korea, confronting rapacious China, and confronting Iran (although, I’m not too sold on the Iranian policy because I think the Jewish lobby has too much influence in that regard – I have no love lost for Iran, and can see a real problem if they go nuclear, but I’d hate to see the US put Israeli needs ahead of US needs).


Regarding the 2020 election, I have grave concerns about the wisdom (lack thereof) of the American voting public. The Dem platform is scary in so many ways – open borders, free college for all, free medical care for all, anti-oil, anti-nuclear power, anti- Western European Judeo-Christian culture, anti-capitalism, against constitutionalists for the Supreme Court, and on and on. I wish I could put more faith in the voting public rejecting such garbage, but Americans are more and more brainwashed by the leftist propaganda espoused by the Media and by Academia.


If God is good, and Trump wins in 2020, then I believe he will then try to make some serious headway against the unsustainable fiscal course this Nation is on. To do that, he and the Nation will need to address Social Security, Medicare, and Medicaid, which are eating up the lion’s share of the budget, and which are growing at an unsustainable rate. The big problem here will be the Congress. Even if the GOP wins the House and the Senate (what are the odds??), it will still be extremely difficult to significantly impact Entitlements, because it’s virtually impossible that the Senate would be 60+ Republicans.


One thing I’ll say about Trump, for all his faults: He’s a man in his 70s, fabulously wealthy, who could have decided to screw this nonsense and retire to his mansions and his golf courses. He’s certainly not doing it for the money. He has a number of good conservative convictions which he is championing for all he’s worth. I hope against hope the voting public will support those convictions in the 2020 election.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 938

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 289

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 309

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 261

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sonic Partners with Obsessed Garage for Home Garage Solutions

Updated Category News Views 147

Sonic Teams Up with Obsessed Garage to Transform Home Garages Sonic, a front-runner in delivering high-quality tool solutions and equipment, has recently announced an exciting partnership with Obsessed Garage. This collaboration aims to cater to home garage enthusiasts who demand tools and storage solutions that match the quality standards utilized by professionals in the...

Continue Reading
Investors of Sun Communities, Inc. Urged to Act Before Deadline

Updated Category News Views 167

Important Update for Sun Communities, Inc. Investors There is a significant call to action for investors of Sun Communities, Inc. as a class action lawsuit has been filed against the company, urging those affected to act promptly. This is a crucial moment for investors who purchased securities from the company during a specific period. Legal representation is being...

Continue Reading
XOMA Stock Reaches New Heights: Key Developments and Insights

Updated Category News Views 67

XOMA Stock Performance Overview XOMA Ltd's stock has recently made headlines by reaching a remarkable 52-week high, with shares trading at an impressive $30.49. This achievement not only signifies a significant milestone for the company but also highlights a robust year-over-year growth that can't be overlooked. Investors have observed a substantial increase of 73.82% in...

Continue Reading
Evolv Technologies Faces Turmoil with Executive Departures

Updated Category News Views 230

Evolv Technologies Faces Turmoil with Executive Departures Evolv Technologies Holdings (NASDAQ: EVLV) is navigating turbulent times following the resignation of its Chief Financial Officer, Mark Donohue. His departure comes amid serious allegations of improper revenue recognition practices that have raised questions about the company's integrity and financial health....

Continue Reading
Editas Medicine: Financial Insights and Market Strategies Revealed

Updated Category News Views 56

Editas Medicine Maintains Price Target Amidst Financial Developments Recently, Leerink Partners reaffirmed a Market Perform rating for Editas Medicine (NASDAQ: EDIT), keeping a price target steady at $8.00. This decision comes closely after the company announced a substantial financing agreement with DRI Healthcare Trust. Under this agreement, Editas is set to receive an...

Continue Reading